Advertisement

Clinical & Experimental Metastasis

, Volume 1, Issue 3, pp 275–287 | Cite as

Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part II. Sequential analysis of serum immune complexes and blocking activity in reconstituted mice in relation to tumour biology

  • D. F. Tucker
  • R. A. Knight
  • Patricia H. Warne
Article
  • 19 Downloads

Abstract

In seven separate experiments, nude (nu/nu) mice carrying established murine sarcoma virus (MSV) tumours were reconstituted with syngeneic (+/+) immune splenic T cells. These immune protected mice were randomly divided to provide smaller groups for serial exsanguination. At various time points mice were individually bled and CIC concentration and blocking activity of each individual serum was determined. Control sera were obtained from nu/nu and adult +/+ mice inoculated with tumour cells only, and from nu/nu mice protected with normal +/+ spleen cells.

In all the mice studied, CIC and blocking appeared to be mutually independent parameters throughout the MSV tumour course. On the other hand, in immune protected mice considered alone or together with the control groups, CIC and time after tumour cell inoculation, but not tumour size, were significantly correlated. A significant relationship between blocking and tumour size was also established, although this only applied to immune protected mice. However, analysis of the combined data from sequentially bled immune protected mice in relation to different phases of tumour behaviour, did not support the notion that blocking, and more particularly the persistence of CIC, contribute to tumour regrowth and dissemination.

Keywords

Tumour Size Sarcoma Nude Mouse Immune Complex Spleen Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Abbreviations

Blocking

inhibition by test sera of cell mediated cytotoxicityin vitro

CIC

circulating immune complexes

MSV

Moloney strain of murine sarcoma virus

NK

natural killing by non-immune lymphocytes

ClgSPA

Clq solid phase assay

EDTA

ethylene diaminetetracetic acid

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    Chun, M., Fernandes, G., andHoffman, M. K., 1981, Mechanism of NK cell activation; relationship between Qa5+ NK cells and lymphocytes.Journal of Immunology,126, 331–336.Google Scholar
  2. [2]
    Dong, Z.-W., Witkin, S. S., Fernandes, G., Sarkar, N. H., Good, R. A., andDay, N. K., 1982, Circulating immune complexes, antigens, and antibodies related to the murine mammary tumour virus in C3H mice.Journal of Immunology,129, 872–876.Google Scholar
  3. [3]
    Eberlein, T. J., Rosenstein, M., andRosenberg, S. A., 1982, Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2.Journal of Experimental Medicine,156, 385–397.Google Scholar
  4. [4]
    Gorczynski, R. M., Kilburn, D. G., Knight, R. A., Norbury, C., Parker, D. C., andSmith, J. B., 1975, Nonspecific and specific immunosuppression in tumour-bearing mice by soluble immune complexes. Nature, London, 254, 141–143.Google Scholar
  5. [5]
    Gordon, J., Holden, H. T., Segal, S., andFeldman, M., 1982, Anti-tumour immunity in B-lymphocyte-deprived mice. III. Immunity to primary Moloney sarcoma virus-induced tumors.International Journal of Cancer,29, 351–357.Google Scholar
  6. [6]
    Hanna, N., Davis, T. W., andFidler, I. J., 1982, Environmental and genetic factors determine the level of NK activity of nude mice and affect their suitability as models for experimental metastasis.International Journal of Cancer,30, 371–376.Google Scholar
  7. [7]
    Hardin, J. A., Walker, L. C., Steers, A. C., Trumble, T. C., Tung, K. S. K., Williams, R. C., Ruddy, S., andMalawista, S. E., 1979, Circulating immune complexes in Lyme Arthritis. Detection by the125I-Clq binding, Clq solid phase, and Raji cell assays.Journal of Clinical Investigation,63, 468–477.Google Scholar
  8. [8]
    Harvey, J., andEast, J., 1971, The murine sarcoma virus (MSV).International Revue of Experimental Pathology,10, 265–360.Google Scholar
  9. [9]
    Herberman, R. B., andHolden, H. T., 1978, Natural cell-mediated immunity.Advances in Cancer Research,27, 305–377.Google Scholar
  10. [10]
    Hellstrom, I., andHellstrom, K. E., 1969, Studies on cellular immunity and its serum-mediated inhibition in Moloney virus-induced mouse sarcomas.International Journal of Cancer,4, 587–600.Google Scholar
  11. [11]
    Hook, D. B. S., Ziola, B., Carlsen, S., Warrington, R., andRamshaw, I., 1983, Circulating immune complexes and immunoglobulin M-class rheumatoid factor in rats bearing mammary adenocarcinomas which vary in ability to metastasise.Cancer Research,43, 114–119.Google Scholar
  12. [12]
    Hunter, W. M., andGreenwood, F. C., 1962, Preparation of iodine-131 labelled human growth hormone of high specific activity.Nature, London,194, 495–496.Google Scholar
  13. [13]
    Jennette, J. C., 1980, Consistent fluctuations in quantities of circulating immune complexes during progressive and regressive phases of tumour growth.American Journal of Pathology,100, 403–409.Google Scholar
  14. [14]
    Jennette, J. C., andFeldman, J. D., 1977, Sequential quantitation of circulating immune complexes in syngeneic and allogeneic rats bearing Moloney sarcomas.Journal of Immunology,118, 2269–2274.Google Scholar
  15. [15]
    Jones, J. M., Kennel, S. J., andFeldman, J. D., 1977, Immunisation with p30 enhances the growth of a rat Moloney sarcoma.Journal of Immunology,118, 371–373.Google Scholar
  16. [16]
    Julius, M. H., Simpson, E., andHerzenberg, L. A., 1973, A rapid method for the isolation of functional thymus-derived murine lymphocytes.European Journal of Immunology,3, 645–650.Google Scholar
  17. [17]
    Knight, R. A., Mitchison, N. A., andShellam, G. R., 1975, Studies on a Gross-virusinduced lymphoma in the rat. II. The role of cell membrane-associated and serum p30 antigen in the antibody and cell-mediated response.International Journal of Cancer,15, 417–428.Google Scholar
  18. [18]
    Lachmann, P. J., andPeters, D. K., 1982, Complement.Clinical aspects of Immunology, Volume I, edited by P. J. Lachmann, and D. K. Peters (Oxford: Blackwell Scientific Publications), p. 27.Google Scholar
  19. [19]
    Lamon, E. W., Skurzak, H. M., Klein, E., andWigzell, H., 1972, In vitro cytotoxicity by a nonthymus-processed lymphocyte population with specificity for a virally determined tumour cell surface antigen.Journal of Experimental Medicine,136, 1072–1079.Google Scholar
  20. [20]
    Leclerc, J..C., Gomard, E., Plata, F., andLevy, J. R., 1973, Cell-mediated immune reaction against tumours induced by oncornaviruses. II. Nature of the effector cells in tumour-cell cytolysis.International Journal of Cancer,11, 426–432.Google Scholar
  21. [21]
    Nair, P. N. M., Fernandes, G., Onoe, K., Day, N. K., andGood, R. A., 1980, Inhibition of effector cell functions in natural killer cell activity (NK) and antibody dependent cellular cytotoxicity (ADCC) in mice by normal and cancer sera.International Journal of Cancer,25, 667–677.Google Scholar
  22. [22]
    O'Brien, T. K., Kendra, J. A., Stephens, H. A. F., Knight, R. A., andBarrett, A. J., 1983, Recognition of marrow elements by natural killer cells: Are NK cells involved in haemopoietic regulation?British Journal of Haematology,53, 161–164.Google Scholar
  23. [23]
    Shellam, G. R., Knight, R. A., Mitchison, N. A., Gorczynski, R. M., andMaoz, A., 1976, The specificity of effector T cells activated by tumours induced by murine oncornaviruses.Transplantation Reviews,29, 249–276.Google Scholar
  24. [24]
    Sjogren, H. O., Hellstrom, I., Bansal, S. C., andHellstrom, K. E., 1971, Suggestive evidence that the “Blocking Antibodies” of tumour-bearing individuals may be antigen antibody complexes.Proceedings of the National Academy of Sciences,68, 1372–1375.Google Scholar
  25. [25]
    Steel, G. G., 1977, Growth rate of tumours. In:Growth Kinetics of Tumours (Oxford: Clarendon Press), p. 5.Google Scholar
  26. [26]
    Theofilopoulos, A. N., Wilson, C. B., andDixon, F. J., 1976, The Raji cell radioimmune assay for detecting immune complexes in human sera.Journal of Clinical Investigation,57, 169–182.Google Scholar
  27. [27]
    Tucker, D. F., Knight, R. A., andWarne, P. H., 1983, Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. I. Biology of tumour regression and recurrence.Clinical & Experimental Metastasis,1, 261–273.Google Scholar
  28. [28]
    Volankis, J., andStroud, R. M., 1972, Rabbit Clq: purification, function and structure.Journal of Immunological Methods,2, 25–34.Google Scholar
  29. [29]
    WHO Memorandum 1981, Use and abuse of eight widely-used diagnostic procedures in clinical immunology.Bulletin of the World Health Organisation,59, 717–728.Google Scholar

Copyright information

© Taylor & Francis Ltd 1983

Authors and Affiliations

  • D. F. Tucker
    • 1
  • R. A. Knight
    • 2
  • Patricia H. Warne
    • 1
  1. 1.Laboratory for Immunological Markers in CancerImperial Cancer Research Fund LaboratoriesLincoln's Inn Fields
  2. 2.Tumour Immunology UnitImperial Cancer Research Fund LaboratoriesLincoln's Inn Fields

Personalised recommendations